- Home
- ORGO vs CLNE Comparison
ORGO vs CLNE Comparison
Compare ORGO & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CLNE
- Stock Information
- Founded
- ORGO 1985
- CLNE 2001
- Country
- ORGO United States
- CLNE United States
- Employees
- ORGO N/A
- CLNE N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CLNE Natural Gas Distribution
- Sector
- ORGO Health Care
- CLNE Utilities
- Exchange
- ORGO Nasdaq
- CLNE Nasdaq
- Market Cap
- ORGO 620.3M
- CLNE 574.5M
- IPO Year
- ORGO N/A
- CLNE 2007
- Fundamental
- Price
- ORGO $4.07
- CLNE $2.92
- Analyst Decision
- ORGO Buy
- CLNE Strong Buy
- Analyst Count
- ORGO 3
- CLNE 5
- Target Price
- ORGO $7.33
- CLNE $3.59
- AVG Volume (30 Days)
- ORGO 765.7K
- CLNE 1.5M
- Earning Date
- ORGO 11-06-2025
- CLNE 11-04-2025
- Dividend Yield
- ORGO N/A
- CLNE N/A
- EPS Growth
- ORGO N/A
- CLNE N/A
- EPS
- ORGO N/A
- CLNE N/A
- Revenue
- ORGO $429,531,000.00
- CLNE $420,579,000.00
- Revenue This Year
- ORGO $2.51
- CLNE $3.49
- Revenue Next Year
- ORGO $25.45
- CLNE $1.71
- P/E Ratio
- ORGO N/A
- CLNE N/A
- Revenue Growth
- ORGO N/A
- CLNE 4.08
- 52 Week Low
- ORGO $2.61
- CLNE $1.30
- 52 Week High
- ORGO $6.71
- CLNE $3.67
- Technical
- Relative Strength Index (RSI)
- ORGO 40.27
- CLNE 65.17
- Support Level
- ORGO $3.84
- CLNE $2.52
- Resistance Level
- ORGO $4.40
- CLNE $2.71
- Average True Range (ATR)
- ORGO 0.22
- CLNE 0.15
- MACD
- ORGO -0.03
- CLNE 0.01
- Stochastic Oscillator
- ORGO 26.79
- CLNE 87.33
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.